• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鹿茸提取物对6-羟基多巴胺诱导的帕金森病大鼠模型的神经退行性变具有保护作用。

Pilose Antler Extracts (PAEs) Protect against Neurodegeneration in 6-OHDA-Induced Parkinson's Disease Rat Models.

作者信息

Li Chaohua, Sun Yanan, Yang Weifeng, Ma Shuhua, Zhang Lili, Zhao Jing, Zhao Xin, Wang Yi

机构信息

Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1 Xiyuan Playground, Haidian District, Beijing 100091, China.

Experimental Research Center, China Academy of Chinese Medical Sciences, No. 16, Nanxiao Road, Dongzhimen, Beijing 100700, China.

出版信息

Evid Based Complement Alternat Med. 2019 Jan 8;2019:7276407. doi: 10.1155/2019/7276407. eCollection 2019.

DOI:10.1155/2019/7276407
PMID:30728849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6341246/
Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative diseases worldwide. Although dopamine replacement therapy mitigates motor dysfunction in PD patients, there are no therapeutics that are currently available to reverse neuronal cell death in the substantia nigra pars compacta (SNc), which is the main region for dopamine loss in PD patients. The protein concentration of the Pilose antler extracts (PAEs) was estimated using the Bradford Protein Assay Kit. Hematoxylin and eosin (HE) staining was used to evaluate the protective effect of PAEs on 6-OHDA induced cell death in PD model rats. Immunohistochemistry (IHC) was used to detect the tyrosine hydroxylase (TH) positive neuronal cell in SNc. HPLC-MS was used to detect dopamine (DA), 3,4-Dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), and glutamate (Glu) levels in the striatum and cerebrospinal fluid (CSF). The amino acid level in the striatum and CSF was measured by HPLC-FLD. Protein expression of growth associated protein-43 (GAP-43) and neurofilament heavy polypeptide (NF-H) was measured using western blotting. The components of PAEs through blood vessels were detected by HPLC/MS/MS. In this study, PAEs with proteins ranging from 10 kDa to 250 kDa molecular weight was administered to 6-OHDA-induced PD rats. We found that PAEs inhibited 6-OHDA-induced neuronal cell death and TH-positive neuronal loss in SNc. PAEs administration also increased the levels of DA, DOPAC, and 5-HT, in addition to DOPAC/DA and HVA/DA indexes in the CSF and Striatum of 6-OHDA induced rats. Conversely, PAEs decreased the levels of Glu and GABA. Treatment with PAEs and Madopar increased GAP-43 and NF-H expression in the SNc and striatum. Proteomic analysis using LC/MS/MS indicated that 11 components of PAEs may have neuropharmacological effects. These results demonstrate that PAEs protects against 6-OHDA induced toxic effects in the PD rat models. Intragastric administration of PAEs may be a novel therapeutic strategy for neurodegenerative disorders like PD.

摘要

帕金森病(PD)是全球最常见的神经退行性疾病之一。尽管多巴胺替代疗法可减轻PD患者的运动功能障碍,但目前尚无治疗方法可逆转黑质致密部(SNc)的神经元细胞死亡,而SNc是PD患者多巴胺缺失的主要区域。使用考马斯亮蓝蛋白定量试剂盒估算鹿茸提取物(PAEs)的蛋白质浓度。采用苏木精-伊红(HE)染色评估PAEs对6-羟基多巴胺(6-OHDA)诱导的PD模型大鼠细胞死亡的保护作用。免疫组织化学(IHC)用于检测SNc中酪氨酸羟化酶(TH)阳性神经元细胞。高效液相色谱-质谱联用(HPLC-MS)用于检测纹状体和脑脊液(CSF)中的多巴胺(DA)、3,4-二羟基苯乙酸(DOPAC)、高香草酸(HVA)、5-羟色胺(5-HT)、5-羟吲哚乙酸(5-HIAA)和谷氨酸(Glu)水平。通过高效液相色谱-荧光检测法(HPLC-FLD)测量纹状体和CSF中的氨基酸水平。使用蛋白质印迹法测量生长相关蛋白-43(GAP-43)和神经丝重链多肽(NF-H)的蛋白表达。通过HPLC/MS/MS检测PAEs通过血管的成分。在本研究中,将分子量范围为10 kDa至250 kDa的含蛋白质的PAEs给予6-OHDA诱导的PD大鼠。我们发现PAEs可抑制6-OHDA诱导的神经元细胞死亡以及SNc中TH阳性神经元的丢失。给予PAEs还可提高6-OHDA诱导大鼠CSF和纹状体中DA、DOPAC和5-HT的水平,以及DOPAC/DA和HVA/DA指数。相反,PAEs可降低Glu和γ-氨基丁酸(GABA)的水平。PAEs与美多芭联合治疗可增加SNc和纹状体中GAP-43和NF-H的表达。使用液相色谱-串联质谱(LC/MS/MS)进行的蛋白质组学分析表明,PAEs的11种成分可能具有神经药理学作用。这些结果表明,PAEs可保护PD大鼠模型免受6-OHDA诱导的毒性作用。胃内给予PAEs可能是一种针对PD等神经退行性疾病的新型治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/017788f78239/ECAM2019-7276407.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/04480f907ae5/ECAM2019-7276407.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/37774c7acd33/ECAM2019-7276407.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/44d329323a28/ECAM2019-7276407.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/cfa13b87da8b/ECAM2019-7276407.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/2827a4bec7b2/ECAM2019-7276407.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/c5996dcf8856/ECAM2019-7276407.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/8bc186ef02cb/ECAM2019-7276407.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/017788f78239/ECAM2019-7276407.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/04480f907ae5/ECAM2019-7276407.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/37774c7acd33/ECAM2019-7276407.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/44d329323a28/ECAM2019-7276407.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/cfa13b87da8b/ECAM2019-7276407.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/2827a4bec7b2/ECAM2019-7276407.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/c5996dcf8856/ECAM2019-7276407.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/8bc186ef02cb/ECAM2019-7276407.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39e0/6341246/017788f78239/ECAM2019-7276407.008.jpg

相似文献

1
Pilose Antler Extracts (PAEs) Protect against Neurodegeneration in 6-OHDA-Induced Parkinson's Disease Rat Models.鹿茸提取物对6-羟基多巴胺诱导的帕金森病大鼠模型的神经退行性变具有保护作用。
Evid Based Complement Alternat Med. 2019 Jan 8;2019:7276407. doi: 10.1155/2019/7276407. eCollection 2019.
2
The subthalamic activity and striatal monoamine are modulated by subthalamic stimulation.丘脑底核刺激可调节丘脑底核活动和纹状体单胺。
Neuroscience. 2014 Feb 14;259:43-52. doi: 10.1016/j.neuroscience.2013.11.034. Epub 2013 Nov 27.
3
Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.鼻内注射胰岛素可防止大鼠黑质多巴胺能神经元丢失,并减轻6-羟基多巴胺诱导的运动功能障碍。
Neuroscience. 2016 Mar 24;318:157-65. doi: 10.1016/j.neuroscience.2016.01.020. Epub 2016 Jan 14.
4
Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.吗多明,一种一氧化氮供体,可调节慢性给予 L-DOPA 治疗的 6-OHDA 损伤大鼠的旋转行为和单胺代谢。
Neurochem Int. 2013 Dec;63(8):790-804. doi: 10.1016/j.neuint.2013.09.021. Epub 2013 Sep 30.
5
A potential target for the treatment of Parkinson's disease: effect of lateral habenula lesions.帕金森病治疗的一个潜在靶点:外侧缰核损伤的影响
Parkinsonism Relat Disord. 2014 Nov;20(11):1191-5. doi: 10.1016/j.parkreldis.2014.08.022. Epub 2014 Sep 1.
6
Study on Effect of Striatal mGluR2/3 in Alleviating Motor Dysfunction in Rat PD Model Treated by Exercise Therapy.纹状体代谢型谷氨酸受体2/3在运动疗法治疗大鼠帕金森病模型中缓解运动功能障碍的作用研究
Front Aging Neurosci. 2019 Oct 2;11:255. doi: 10.3389/fnagi.2019.00255. eCollection 2019.
7
Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions.脑源性神经营养因子和神经营养素-3对与部分黑质纹状体多巴胺损伤相关的神经化学和行为缺陷的疗效。
J Neurochem. 1994 Sep;63(3):1021-32. doi: 10.1046/j.1471-4159.1994.63031021.x.
8
Therapeutic effect of human amniotic epithelial cell transplantation into the lateral ventricle of hemiparkinsonian rats.人羊膜上皮细胞移植入半侧帕金森病大鼠侧脑室的治疗效果。
Chin Med J (Engl). 2009 Oct 20;122(20):2449-54.
9
Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.多巴胺 D2 受体是 REM 睡眠剥夺介导的黑质致密部神经元激活的关键因素。
Neuropharmacology. 2014 Jan;76 Pt A:118-26. doi: 10.1016/j.neuropharm.2013.08.024. Epub 2013 Sep 4.
10
The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.Kv7/KCNQ 通道阻断剂 XE991 可保护帕金森病 6-羟多巴胺大鼠模型中的黑质多巴胺能神经元。
Brain Res Bull. 2018 Mar;137:132-139. doi: 10.1016/j.brainresbull.2017.11.011. Epub 2017 Nov 22.

引用本文的文献

1
Intranasal delivery of dodecyl creatine ester alleviates motor deficits and increases dopamine levels in a 6-OHDA rat model of parkinsonism.在帕金森病6-OHDA大鼠模型中,经鼻给药十二烷基肌酸酯可减轻运动功能障碍并提高多巴胺水平。
Front Aging Neurosci. 2025 Jul 11;17:1597263. doi: 10.3389/fnagi.2025.1597263. eCollection 2025.
2
Calcineurin-mediated regulation of growth-associated protein 43 is essential for neurite and synapse formation and protects against α-synuclein-induced degeneration.钙调神经磷酸酶介导的生长相关蛋白43调节对于神经突和突触形成至关重要,并可防止α-突触核蛋白诱导的变性。
Front Aging Neurosci. 2025 Apr 7;17:1566465. doi: 10.3389/fnagi.2025.1566465. eCollection 2025.
3

本文引用的文献

1
Protective effects of Cervus nippon Temminck velvet antler polypeptides against MPP+‑induced cytotoxicity in SH‑SY5Y neuroblastoma cells.梅花鹿鹿茸多肽对 MPP+诱导的 SH-SY5Y 神经母细胞瘤细胞毒性的保护作用。
Mol Med Rep. 2017 Oct;16(4):5143-5150. doi: 10.3892/mmr.2017.7303. Epub 2017 Aug 21.
2
Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats.慢病毒介导的胱硫醚-β-合酶过表达对6-羟基多巴胺诱导的帕金森病大鼠的神经保护作用
Neurosci Lett. 2017 Sep 14;657:45-52. doi: 10.1016/j.neulet.2017.07.019. Epub 2017 Jul 29.
3
Regulation of Intracellular Structural Tension by Talin in the Axon Growth and Regeneration.
Protective effects of enzymatically digested velvet antler polypeptides on mitochondria in primary astrocytes.
酶解鹿茸多肽对原代星形胶质细胞线粒体的保护作用
J Anim Sci Technol. 2025 Jan;67(1):164-178. doi: 10.5187/jast.2023.e135. Epub 2025 Jan 31.
4
A high performance liquid chromatography tandem mass spectrometry protocol for detection of neurotransmitters in the rat brain tissue.一种用于检测大鼠脑组织中神经递质的高效液相色谱串联质谱分析方法。
MethodsX. 2023 Feb 18;10:102083. doi: 10.1016/j.mex.2023.102083. eCollection 2023.
5
Health Effects of Peptides Extracted from Deer Antler.鹿茸提取肽的健康影响。
Nutrients. 2022 Oct 8;14(19):4183. doi: 10.3390/nu14194183.
6
Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in and Parkinson's Disease Models.雌二醇加氯化锂通过抗凋亡和神经发生途径对大鼠和小鼠帕金森病模型的神经保护作用
Parkinsons Dis. 2021 Oct 22;2021:3064892. doi: 10.1155/2021/3064892. eCollection 2021.
7
GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases.生长相关蛋白43和脑酸性可溶性蛋白1在轴突再生中的作用:对神经退行性疾病治疗的启示
Front Cell Dev Biol. 2020 Sep 3;8:567537. doi: 10.3389/fcell.2020.567537. eCollection 2020.
8
Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease.Wnt1 促进 EAAT2 的表达,并介导星形胶质细胞对帕金森病中多巴胺能细胞的保护作用。
Neural Plast. 2019 Sep 9;2019:1247276. doi: 10.1155/2019/1247276. eCollection 2019.
踝蛋白对轴突生长和再生过程中细胞内结构张力的调控
Mol Neurobiol. 2016 Sep;53(7):4582-95. doi: 10.1007/s12035-015-9394-9. Epub 2015 Aug 23.
4
Protein prenylation and synaptic plasticity: implications for Alzheimer's disease.蛋白质异戊二烯化与突触可塑性:对阿尔茨海默病的影响
Mol Neurobiol. 2014 Aug;50(1):177-85. doi: 10.1007/s12035-013-8627-z. Epub 2014 Jan 5.
5
What's hAPPening at synapses? The role of amyloid β-protein precursor and β-amyloid in neurological disorders.突触处发生了什么?淀粉样β蛋白前体和β-淀粉样蛋白在神经退行性疾病中的作用。
Mol Psychiatry. 2013 Apr;18(4):425-34. doi: 10.1038/mp.2012.122. Epub 2012 Aug 28.
6
[In vitro study on gastrointestinal absorption of FITC labeled pilose antler protein extraction].[异硫氰酸荧光素标记鹿茸蛋白提取物的胃肠道吸收体外研究]
Yao Xue Xue Bao. 2011 Dec;46(12):1526-9.
7
Neuronal dystonin isoform 2 is a mediator of endoplasmic reticulum structure and function.神经元肌联蛋白 2 异构体是内质网结构和功能的介质。
Mol Biol Cell. 2012 Feb;23(4):553-66. doi: 10.1091/mbc.E11-06-0573. Epub 2011 Dec 21.
8
Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.纹状体中血清素和多巴胺神经支配在帕金森病和亨廷顿舞蹈病中的作用。
Parkinsonism Relat Disord. 2011 Sep;17(8):593-8. doi: 10.1016/j.parkreldis.2011.05.012. Epub 2011 Jun 12.
9
Levodopa in Parkinson's disease: from the past to the future.左旋多巴治疗帕金森病:从过去到未来。
Expert Opin Pharmacother. 2010 Mar;11(4):627-35. doi: 10.1517/14656561003598919.
10
Levodopa delivery systems: advancements in delivery of the gold standard.左旋多巴给药系统:金标准给药的进步。
Expert Opin Drug Deliv. 2010 Feb;7(2):203-24. doi: 10.1517/17425240903483166.